TP53 and glioblastoma: Considering the importance of TMZ in GBM therapy, we aimed at investigating, first, the cytotoxic effect of MET in a variety of GBM cell lines differing in their p53 status and primary GBM cells and, secondly, to assess the contribution of MET to doxorubicin and TMZ-induced cytotoxicity in these cells.